Provectus to Hold Conference Call Tuesday, June 3, 2014
Call Will Review Scientific Content of ASCO Posters
Call Will Detail Regulatory Path Forward for PV-10
KNOXVILLE, Tenn.--(BUSINESS WIRE)--
Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT) (http://www.pvct.com/), a development-stage oncology and dermatology biopharmaceutical company, announced today that it will hold a conference call on Tuesday, June 3, 2014 at 8:30 a.m. EDT.
The purpose of the call will be to update the market on the scientific content of the two poster presentations at American Society of Clinical Oncology (ASCO) annual meeting to be held at McCormick Place, Chicago, IL. In addition, the Company will lay out its plans for securing FDA approval for the use of PV-10 in the treatment of cutaneous melanoma.
As indicated in the Company’s press releases issued on May 14, 2014 and May 15, 2014, these presentations, undertaken separately by Moffitt Cancer Center and St. Luke’s Cancer Center, show that IL PV-10 (a) can potentially offer cancer patients control of their cutaneous symptoms and (b) elicit a systemic anti-tumor immune response that may lead to response of uninjected lesions (the “bystander effect” that has been observed in prior clinical studies of PV-10).
The FDA has said that the data Provectus presented in its application for breakthrough therapy designation were “indicative of drug activity in the treatment of local, satellite or in-transit recurrence of malignant melanoma.” These studies illustrate that statement.
The Company will also use the conference call to explain its plans for attempting to meet the FDA’s suggested end points and for trying to obtain approval for PV-10.
Conference Call Tuesday June 3, 2014, at 8:30 AM EDT
The management of Provectus Biopharmaceuticals, Inc. will host a conference call on Tuesday, June 3 at 8:30 AM Eastern. Those who wish to participate in the conference call may telephone 877-407-4019 from the U.S. International callers may telephone 201-689-8337, approximately 15 minutes before the call. A webcast will also be available at: www.pvct.com.
A digital replay will be available by telephone approximately two hours after the completion of the call until August 3, 2014, and may be accessed by dialing 877-660-6853 from the U.S. or 201-612-7415 for international callers, and using the Conference ID#13583791.
finance.yahoo.com … 00433.html |
